UCB PHARMA GMBH

ABILERO

Pharmaceutical preparations and substances for the treatment of central and peripheral nervous system diseases, urological diseases, heart and circulatory diseases, hypertension, and gastrointestinal disorders;

BENTIVO

Pharmaceutical preparations and substances for the treatment of central and peripheral nervous system diseases, urological diseases, heart and circulatory diseases, hypertension, and gastrointestinal disorders;

BONPRO

PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES, UROLOGICAL DISEASES, METABOLIC DISEASES, CARDIOVASCULAR DISEASES, HYPERTENSION, AND GASTROENTEROPATHY;

BRINAMIC

Statement(s): Column 1, line 8 through 11 and substances, and peripheral nervous system diseases, urological diseases, heart and circulatory diseases, hypertension, and gastrointestinal disorders should be deleted, and sold under prescription should be inserted at the end.;Pharmaceutical preparations [ and substances ] for the treatment of central [ and peripheral ] nervous system diseases, [ urological diseases, heart and circulatory diseases, hypertension, and gastrointestinal disorders ] * sold under prescription only *;

CUPEDAN

pharmaceutical preparations and substances for the treatment of central and peripheral nervous system diseases, heart and circulatory diseases, hypertension, cardiovascular diseases, urological diseases, gastrointestinal diseases, metabolic diseases, chronic peripheral arterial occlusive diseases, inflammatory diseases, antiallergic preparations, and analgesic preparations;

EXENTRO

pharmaceutical preparations and substances for the treatment of central and peripheral nervous system diseases, heart and circulatory diseases, hypertension, cardiovascular diseases, urological diseases, gastrointestinal diseases, metabolic diseases, chronic peripheral arterial occlusive diseases, inflammatory diseases, antiallergic preparations, and analgesic preparations;

LEGANTO

Class 5, should be Pharmaceutical preparations containing rotigotine as active substance, for the treatment of restless legs syndrome (in the form of patches) and Parkinson's disease;Pharmaceutical preparations [ and substances ] * containing rotigotine as active substance * for the treatment of [ central and peripheral nervous system diseases, urological diseases, heart and circulatory diseases, hypertension, and gastrointestinal disorders ] * restless legs syndrome (in the form of patches) and Parkinson's disease *;

NEUPRO

PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES, SOLD UNDER PRESCRIPTION ONLY;

NEUPRO

[ Electronic publishing services, namely, publication of articles of others on CD, DVD, and online featuring central nervous system diseases; publication of magazines and books ];The mark consists of the word NEUPRO in blue letters next to a green square design.;Pharmaceutical preparations and substances for the treatment of diseases of the central nervous system;Printed teaching and educational materials in the field of the central nervous system for use by physicians and pharmacists;The color(s) green and blue is/are claimed as a feature of the mark.;

NEURO SPEED DATING

Arranging and conducting seminars and workshops in the field of medicine;The mark consists of the phrase NEURO SPEED DATING in gray letters; on the right side of the phrase are two interlocking red boxes and five smaller red boxes; on the left side of the phrase are four interlocking red boxes and three smaller red boxes; the white background color is not claimed.;The color(s) red and gray is/are claimed as a feature of the mark.;NEURO;

OPERNO

pharmaceutical preparations and substances for the treatment of central and peripheral nervous system diseases, heart and circulatory diseases, hypertension, cardiovascular diseases, urological diseases, gastrointestinal diseases, metabolic diseases, chronic peripheral arterial occlusive diseases, inflammatory diseases, antiallergic preparations, and analgesic preparations;

PENPROX

pharmaceutical preparations and substances for the treatment of central and peripheral nervous system diseases, heart and circulatory diseases, hypertension, cardiovascular diseases, urological diseases, gastrointestinal diseases, metabolic diseases, chronic peripheral arterial occlusive diseases, inflammatory diseases, antiallergic preparations, and analgesic preparations;

PROMTIC

pharmaceutical preparations and substances for the treatment of central and peripheral nervous system diseases, heart and circulatory diseases, hypertension, cardiovascular diseases, urological diseases, gastrointestinal diseases, metabolic diseases, chronic peripheral arterial occlusive diseases, inflammatory diseases, antiallergic preparations, and analgesic preparations;

PROVIDA

Pharmaceutical preparations for the treatment of central nervous system diseases, only available on prescription;

RALEXO

Pharmaceutical preparations and substances for the treatment of central and peripheral nervous system diseases, heart and circulatory diseases, hypertension, cardiovascular diseases, urological diseases, gastrointestinal disorders, metabolic diseases, chronic peripheral arterial occlusive diseases, inflammatory diseases, antiallergic preparations, sold by prescription only, and analgesic preparations;

RINIVA

Pharmaceutical preparations and substances for the treatment of central or peripheral nervous system diseases, heart and circulatory diseases, hypertension, cardiovascular diseases, urological diseases, gastrointestinal disorders, metabolic diseases, chronic peripheral arterial occlusive diseases, inflammatory diseases, antiallergic preparations, sold by prescription only, and analgesic preparations;

SCHWARZ PHARMA

Publication and issuing of electronic versions of printed material, namely, publications on the Internet, issuing of magazines and books in electronic form on the World Wide Web;The mark consists of the color red appearing in the line that divides the words SCHWARZ PHARMA and the color black appearing in the all wording in the mark.;Pharmaceutical preparations for the treatment of heart and circulatory diseases and hypertension, vascular diseases, urological diseases, central and peripheral nervous system diseases, gastrointestinal disorders, metabolic disorders, peripheral arterial occlusive diseases, migraines, iron deficiency, and disturbances of blood supply;Printed teaching and training materials in the field of pharmaceuticals and healthcare products for doctors and pharmacists;Telecommunications services, namely, transmission of information and providing access to platforms and portals on the World Wide Web for the transfer and dissemination of a wide range of information;The color(s) red, black is/are claimed as a feature of the mark.;Distribution of printed materials, newspapers, magazines, books and audiovisual media for advertising purposes; services with regard to product presentation of pharmaceutical and healthcare product companies to the public over the internet and other media;Pharmaceutical consultancy upon use and application of pharmaceutical preparations and healthcare products;Scientific research services related to the use and application of pharmaceutical preparations and healthcare products as well as development services related to new pharmaceutical preparations and healthcare products;

SINTOBÉN

pharmaceutical preparations and chemo-pharmaceutical preparations for the treatment of central and peripheral nervous system diseases, urological disorders, heart and circulatory disorders, gastrointestinal problems, metabolic diseases, and migraines; pharmaceutical preparations and chemo-pharmaceutical preparations, namely, anti-allergic substances, dermatics, antibiotics, analgesics and antirheumatics, antiphlogistics, and cytostatic agents and metastasis inhibitors for the treatment of cancer;